Exercise after chemo: new trial tests if running and walking can keep colorectal cancer at bay

NCT ID NCT03822572

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study tests whether a structured endurance exercise program, like walking or cycling, after finishing chemotherapy can help prevent colorectal cancer from returning. About 92 patients who have completed adjuvant chemotherapy will be randomly assigned to either an exercise program or their usual physical activity. Researchers will track how long they live without cancer coming back and overall survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
endurance exercise program
What this could lead to
If it works, this could show that a structured exercise program after chemotherapy helps prevent cancer from coming back and improves survival.
What could go wrong
This is a small, early-stage trial with only 92 participants, so results may not apply to everyone. Previous studies on exercise after chemotherapy have had mixed results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BKH Kufstein

    Kufstein, Tyrol, 6330, Austria

  • Hospital BHS Linz, Coop. Study Group

    Linz, Upper Austria, 4010, Austria

  • KH St. Josef Braunau

    Braunau am Inn, Upper Austria, 5280, Austria

  • Kepler Universitätsklinikum Linz

    Linz, Upper Austria, 4020, Austria

  • Klinikum Wels-Grieskirchen

    Wels, Upper Austria, 4600, Austria

  • LKH Salzburg-PMU, UNiv. KLinik f. Innere Med III

    Salzburg, State of Salzburg, 5020, Austria

  • Med. Univ. Graz

    Graz, Styria, 8036, Austria

  • Pyhrn-Eisenwurzen Klinikum Steyr

    Steyr, Upper Austria, 4400, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.